About 300 reports

HER##-Negative Breast Cancer:

  • Breast Cancer
  • World
  • Cancer Incidence
  • Breast Screening Coverage

##.## Growing Breast Cancer Prevalence Across Asia Pacific

  • Breast Cancer
  • APAC
  • Breast Screening Coverage
  • Cause-Specific Mortality Rate

Abstract: - Global Breast Cancer Therapeutics Market to Reach $29.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Breast Cancer Therapeutics estimated at US$17.2 Billion in the year 2020, is projected to reach a revised size of US$29.8 Billion by 2027, growing at a CAGR of 8.2% over the analysis...

  • Breast Cancer
  • Therapy
  • World
  • China
  • United States

Abstract: - Global Breast Cancer Screening Market to Reach $22 Billion by 2027 - Amid the COVID-19 crisis, the global market for Breast Cancer Screening estimated at US$13.7 Billion in the year 2020, is projected to reach a revised size of US$22 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027....

  • Hospital
  • Diagnostics
  • Breast Cancer
  • World
  • China
  • United States
  • Breast Screening Coverage

##. Breast Cancer Screening – Market Landscape

  • Breast Cancer
  • Europe
  • Breast Screening Coverage
  • Drug Approval

“HR+/ HER2-VE Breast Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in HR+/ HER2-VE Breast Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage,...

  • Breast Cancer
  • World

Abstract: - Global Breast Cancer Liquid Biopsy Market to Reach $936.3 Million by 2027 - Amid the COVID-19 crisis, the global market for Breast Cancer Liquid Biopsy estimated at US$262.6 Million in the year 2020, is projected to reach a revised size of US$936.3 Million by 2027, growing at a CAGR of 19.9% over the analysis...

  • Genetic Testing
  • Breast Cancer
  • World
  • China
  • United States

##. Breast Cancer Screening – Market Landscape

  • Breast Cancer
  • North America
  • United States
  • Breast Screening Coverage
  • Cervical Cancer Screening Coverage

## Europe: Breast Cancer Screening Market

  • Breast Cancer
  • APAC
  • World
  • Breast Screening Coverage
  • Cause-Specific Mortality Rate

Major players in the breast cancer drugs market are F. Hoffmann-La Roche Ltd, Novartis AG, AstraZeneca, Eli Lilly and Company, and Celgene Corporation. The global breast cancer drugs market is expected to grow from $14.25 billion in 2020 to $14.82 billion in 2021 at a compound annual growth rate (CAGR) of 4%. The growth is mainly due...

  • Breast Cancer
  • World

"US Breast Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • US Breast Cancer Drug Market: > USD 20 Billion Opportunity by 2026 • US Breast Cancer clinical Trials: 350 Drugs in Pipeline • More Than 130 Drugs in Phase II & Higher Phases of Trials • Detailed...

  • Breast Cancer
  • United States
  • Drug Approval

Breast Cancer Liquid Biopsy Market Report Overview Breast Cancer Liquid Biopsy market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Breast Cancer Liquid Biopsy market types and applications. It is a focused study on Breast Cancer Liquid...

  • Genetic Testing
  • Breast Cancer
  • World
  • APAC
  • Health Provider Density

Breast Cancer Screening Test Market Report Overview Breast Cancer Screening Test market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Breast Cancer Screening Test market types and applications. It is a focused study on Breast Cancer Screening...

  • Breast Cancer
  • World
  • Health Provider Density

Major players in the breast cancer monoclonal antibodies (mAbs) market are Amgen, Mylan, Merck, Novartis, GlaxoSmithKline, Daiichi Sankyo, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, and Array BioPharma. The global breast cancer monoclonal antibodies market is expected to decline from $13.57 billion in 2019 to $12.60 billion...

  • Breast Cancer
  • Monoclonal Antibody
  • World
  • Cancer Mortality
  • Oncology Drug Sales

HER-2 Negative Breast Cancer Market Report Overview HER-2 Negative Breast Cancer market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across HER-2 Negative Breast Cancer market types and applications. It is a focused study on HER-2 Negative Breast...

  • Breast Cancer
  • World
  • Health Provider Density

The leading cause of cancer deaths in women globally is breast cancer.Regular breast cancer screening is imperative for early detection and timely intervention. Screening mammography is the method most commonly used worldwide for the detection of breast cancer.However, the traditional methods of screening are plagued by several challenges. Over...

  • Breast Cancer
  • World
  • Cancer Mortality
  • Breast Screening Coverage

Breast Cancer Screening Market, Global Forecast by Screening Test, Population, Countries, Company Analysis Globally, breast cancer is considered one of the most common cancers in women around the world. Breast cancer is also a leading cause of death from cancer in the world’s least developed nations....

  • Breast Cancer
  • World
  • Breast Screening Coverage
  • Cancer Mortality

" Global Breast Cancer Drug Market & Clinical Trial Insight 2025" Report Highlights: • Global Breast Cancer Drug Market: US$ 40 Billion Opportunity • Global Breast Cancer Drug Clinical Pipeline: More Than 550 Drugs • Marketed Breast Cancer Drugs: More Than 90 Drugs • Comprehensive Clinical Insight &...

  • Breast Cancer
  • World

Breast Cancer Liquid Biopsy Market by Product & Service (Reagent Kits, Instruments, and Services), Circulating Biomarker (Circulating Tumor Cells, Extracellular Vesicles, and Circulating Tumor DNA), and Application (Diagnostics, Prognostics, and Risk Assessment): Global Opportunity Analysis and Industry Forecast, 2019–2027 The...

  • Genetic Testing
  • Breast Cancer
  • World
  • APAC

The research service provides an overview of the interventional oncology devices market for breast cancer in big five countries in Europe and in the United States. The study provides a four-year forecast from 2016 to 2020. The unique value of this study is that it provides insights gathered from more than 100 end users, including...

  • Breast Cancer
  • Europe
  • United States

"US Breast Cancer Drug Market, Price, Dosage & Clinical Pipeline Insight 2025" Report Highlights: • US Breast Cancer Drug Market Opportunity: US$ 20 Billion • US Breast Cancer Drug Clinical Pipeline by Company, Phase, Drug Class & Patient Segment • US Breast Cancer Marketed Drugs: 42 Drugs • US Breast...

  • Breast Cancer
  • United States

Report Scope: This report is an update to Breast Cancer Diagnostics and Therapeutics Market Report-HLC106B. The objective of the current report is to provide readers with updated market estimates for the diagnostics and therapeutics market. This report also highlights current and future market potential for breast...

  • Breast Cancer
  • World
  • Cancer Incidence
  • Cancer Mortality

Hormone Sensitive Breast Cancer (Oncology) - Drugs in Development, 2021 Summary Hormone Sensitive Breast Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Hormone Sensitive Breast Cancer pipeline landscape. The report provides comprehensive information on the therapeutics...

  • Breast Cancer
  • World

Major players in the breast cancer diagnostics market are Abbott Laboratories, Myriad Genetics Inc, Hologic Inc, Koninklijke Philips N.V., Fujifilm Holdings Corporation, GE Healthcare, Thermo Fischer Scientific Inc, Siemens AG, NanoString Technologies Inc, and C. R. Bard Inc. The global breast cancer diagnostics market is expected to...

  • Breast Cancer
  • United States
  • World
  • Cancer Mortality
  • Mortality Rate

The ongoing clinical trial research report- “2019 Hormone Refractory Breast Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Hormone Refractory Breast Cancer trials across the world. The report presents top level analysis of global Hormone Refractory Breast Cancer clinical trials across countries, companies...

  • Breast Cancer
  • Clinical Trial
  • World
  • APAC

The ongoing clinical trial research report- “2019 Hormone Sensitive Breast Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Hormone Sensitive Breast Cancer trials across the world. The report presents top level analysis of global Hormone Sensitive Breast Cancer clinical trials across countries, companies and...

  • Breast Cancer
  • Clinical Trial
  • World
  • APAC

Breast Cancer Diagnostics Global Market Report 2020-30: Covid 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global breast cancer diagnostics market. This report focuses on breast cancer diagnostics market which is experiencing strong growth. The report...

  • Breast Cancer
  • Diagnostics
  • World

Global Next-Generation Breast Cancer Diagnostics and Screening Market to Reach $10.48 Billion by 2030 Market Report Coverage - Next Generation Breast Cancer Diagnostic and Screening Market Segmentation • Product Type - BRCA tests, ER/PR tests, HER2 tests • Technology- Real-Time Polymerase...

  • Breast Cancer
  • Diagnostics
  • World
  • APAC
  • North America
  • Breast Screening Coverage

‘Hormone Receptor (HR) positive/ Human Epidermal Receptor 2 (HER2) negative Breast Cancer-Market Insights, Epidemiology and Market Forecast–2030’ report delivers an in-depth understanding of the HR-positive/ HER2-negative breast cancer, historical and forecasted epidemiology as well as the HR-positive/ HER2-negative breast cancer market trends...

  • Breast Cancer
  • United States
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Japan
  • Health Expenditure

GLOBAL BREAST CANCER PATIENT POPULATION (## MILLION)

  • Breast Cancer
  • Magnetic Resonance Imaging
  • Nuclear Imaging Equipment
  • United States
  • Europe
  • APAC
  • North America
  • Breast Screening Coverage
  • Health Expenditure